NEWS: As part of the rapid global response to the 2019 novel coronavirus, HHS's PHEgov will use an existing partnership with Janssen Research & Development, part of Johnson & Johnson, to help develop treatments for coronavirus infections.
to enhance national security and the public health by modernizing influenza vaccines and technologies.
This expanded collaboration with Sanofi is BARDA’s second program to focus on developing a novel coronavirus vaccine candidate in the past few weeks. There is currently no approved vaccine, treatment, or diagnostic for novel coronavirus infections; however, the U.S. Food and Drug Administration has issued an emergency use authorization to enable emergency use of a diagnostic test developed by the Centers for Disease Control and Prevention.
BARDA also is working with counterparts across the government, including within HHS and with the Department of Defense. The team is reviewing potential vaccines, treatments and diagnostics from across the public and private sectors, particularly products in development for Middle East Respiratory Syndrome or Severe Acute Respiratory Syndrome , to identify promising candidates for development and licensure to detect, protect against or treat novel coronavirus infections.
To obtain information about any potential products in development in the private sector that could be used in responding to the novel coronavirus outbreak, the U.S. government launched a single point-of-entryfor innovators and product developers to submit brief descriptions of their diagnostics, therapeutics, vaccines, and other products or technologies relevant to this new virus.
Federal agencies are particularly interested in identifying products and technologies that have progressed into or beyond non-clinical studies, have established large-scale commercial Good Manufacturing Practices manufacturing capability, and/or have utilized a platform already approved by the U.S. Food and Drug Administration .
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
2019 Novel Coronavirus (2019-nCoV)While CDCgov considers COVID19 a serious situation and is taking preparedness measures, the immediate risk in the U.S. is considered low. Everyone should always take simple precautions to help prevent the spread of respiratory illnesses. coronavirus
Read more »
Sanofi researching coronavirus vaccine with BARDA, using SARS vaccine - Business InsiderSanofi said Tuesday it is working with US health authorities to develop a coronavirus vaccine, using prior research against SARS.
Read more »
HSBC sets new cost cutting, profit targets after 2019 profit falls 33%HSBC Holdings PLC on Tuesday unveiled plans to cut costs and simplify its struct...
Read more »
This Dessert-Inspired Hair Color Will Convince You to Go Blonde in 2019The 'smoked marshmallow' hair color trend might convince you to go blonde:
Read more »
Manatee deaths in Florida drop to 606 in 2019Experts say it appears the main cause of the decline in deaths is the reduced effect of red tide algae on manatees:
Read more »
Car parts group Faurecia 2019 profits rise, sees challenging market in 2020French car parts group Faurecia reported a rise in annual profits and sales, and...
Read more »